Blaine Mooers to Thyroid Neoplasms
This is a "connection" page, showing publications Blaine Mooers has written about Thyroid Neoplasms.
Connection Strength
0.216
-
Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. Ann Oncol. 2021 02; 32(2):261-268.
Score: 0.178
-
Drug resistance profiles of mutations in the RET kinase domain. Br J Pharmacol. 2018 09; 175(17):3504-3515.
Score: 0.038